Vancomycin Reduction Practices (VRP) in the NICU

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChildren's Hospital of Philadelphia

About this trial

This multi-center, cluster randomized study aimed at improving implementation of vancomycin reducing practices (VRP) in neonatal intensive care units (NICUs). Sites will be recruited and randomized to receive either external facilitation or no external facilitation to assess the effect on center-level fidelity to the core components of VRP implementation. Interventions available to both study arms are directed at hospital staff and includes identification of local champions, educational outreach, unit-level audit \& feedback, and use of a clinical decision support tool.

Eligibility criteria

Qualifiers

Level III NICU

Affiliated with Kaiser Permanente Northern California (KPNC) or Children's Hospital of Philadelphia Newborn Care Network (CNBCN)

Recruited by study team

Disqualifiers

Site not recruited for the study

Trial design

Treatments tested in this trial

  • External Facilitation

Treatment groups

13 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Children's Hospital of Philadelphia

Lead sponsor

Agency for Healthcare Research and Quality (AHRQ)

Collaborator